Today most treatments with regional hyperthermia are applied using rad
iofrequency systems with 'focus' steering by amplitude and phase contr
ol. This paper deals with quality assurance procedures developed to en
sure controlled and safe treatments in such systems. Our results show
how the deviations between requested and observed phase and amplitude
vary with frequency, and how these deviations depend on both the geome
try of the object (phantom) inside the system and the power level appl
ied. The results also indicate that the investigated systems' internal
quality assurance procedures were inadequate and that additional proc
edures should be applied. Since the system parameters depend on patien
t and treatment specific conditions it is concluded that there is a ne
ed for QA measurements before or during treatment. This paper deals sp
ecifically with the commercial BSD-2000 system from BSD Medical Corp.
in Salt Lake City, Utah, as installed in Bergen, but the procedure out
lined can be applied to other phase and amplitude-controlled RF-RHT sy
stems with only minimal adjustments.